459 reports of this reaction
1.9% of all DALTEPARIN SODIUM reports
#9 most reported adverse reaction
DIARRHOEA is the #9 most commonly reported adverse reaction for DALTEPARIN SODIUM, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 459 FDA adverse event reports linking DALTEPARIN SODIUM to DIARRHOEA. This represents approximately 1.9% of all 23,703 adverse event reports for this drug.
Patients taking DALTEPARIN SODIUM who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DIARRHOEA is a less commonly reported adverse event for DALTEPARIN SODIUM, but still significant enough to appear in the safety profile.
In addition to diarrhoea, the following adverse reactions have been reported for DALTEPARIN SODIUM:
The following drugs have also been linked to diarrhoea in FDA adverse event reports:
DIARRHOEA has been reported as an adverse event in 459 FDA reports for DALTEPARIN SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
DIARRHOEA accounts for approximately 1.9% of all adverse event reports for DALTEPARIN SODIUM, making it a notable side effect.
If you experience diarrhoea while taking DALTEPARIN SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.